Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of bacterial infections
3.2.1.2 Growing collaborations for development of antibiotics
3.2.1.3 Increasing focus on generic medications
3.2.2 Industry pitfalls & challenges
3.2.2.1 Increasing prevalence of antibiotic resistance
3.2.2.2 High competition from other antibiotics
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Generation, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 First generation cephalosporins
5.3 Second generation cephalosporins
5.4 Third generation cephalosporins
5.5 Fourth generation cephalosporins
5.6 Fifth generation cephalosporins
Chapter 6 Market Estimates and Forecast, By Indication, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Respiratory infections
6.3 Urinary tract infections (UTIs)
6.4 Skin and soft tissue infections
6.5 Sexually transmitted infections (STIs)
6.6 Gastrointestinal infections
6.7 Other indications
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Parenteral
7.4 Topical
Chapter 8 Market Estimates and Forecast, By Drug Type, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Branded
8.3 Generic
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospital pharmacy
9.3 Retail pharmacy
9.4 Online pharmacy
Chapter 10 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 AbbVie Inc.
11.2 Bristol-Myers Squibb Company
11.3 Eli Lilly and Company
11.4 F. Hoffmann-La Roche Ltd.
11.5 Merck & Co., Inc.
11.6 Mylan N.V.
11.7 Novartis AG
11.8 Pfizer Inc.
11.9 Sanofi
11.10 Sun Pharmaceutical Industries Ltd.
11.11 Teva Pharmaceutical Industries Ltd.
